| Date |
Research Question / Title |
Unique ID |
Research Team |
|
March 30, 2020
|
Where and how are they producing and using intubation hoods?
|
EOC033001 RR
|
EOC
|
|
April 1, 2020
|
What is the degree of COVID-19 transmission through the administration of nebulizer medication either in clinical practice or in animal experiments?
|
EOC040101 RR
|
EOC
|
|
April 4, 2020
|
What is the evidence for early implementation of field hospitals for COVID-19?
|
EOC040203 RR
|
EOC
|
|
April 6, 2020
|
What is the evidence for the effectiveness of face masks for preventing the spread of COVID-19 in the community?
|
EOC040601 RR
|
EOC
|
|
April 7, 2020
|
What is the prevalence of sore throat as a symptom of COVID-19?
|
EOC040201 RR
|
EOC
|
|
April 11, 2020
|
Is the IgM or IgG immune response protective?
|
LAB040803 RR
|
Laboratory
|
|
April 15, 2020
|
At what time in the disease timeline of COVID-19 do antibodies develop?
|
LAB041402 RR
|
Laboratory
|
|
April 23, 2020
|
What sampling method is most appropriate for population testing?
|
LAB042201 RR
|
Laboratory
|
|
April 25, 2020
|
What frequency of repeat population screening will be required?
|
LAB042202 RR
|
Laboratory
|
|
April 27, 2020
|
What is the period of communicability of symptomatic SARS-CoV-2?
|
INF042401 RR
|
Infectious Disease
|
|
April 27, 2020
|
What is the best evidence to guide the sequence or priority of re-opening each type of healthcare service and how have the closures impacted patients?
|
EOC042202 RR
|
EOC
|
|
April 28, 2020
|
What is the sensitivity and specificity of screening checklists and temperature checks for detecting the presence of COVID-19 in individuals?
|
PH042401 RR
|
Public Health
|
|
April 30, 2020
|
How is "compassionate visit" defined and operationalized in the context of an infectious outbreak or pandemic?
|
LTC042402 RR
|
Long Term Care
|
|
May 7, 2020
|
What are best practices for engaging family care providers during a pandemic?
|
LTC042401 RR
|
Long Term Care
|
|
May 8, 2020
|
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
|
LAB040701v2 RR
|
Laboratory
|
|
May 11, 2020
|
What percentage of COVID-19 patients have hyposmia or anosmia?
|
EOC033102 RR
|
EOC
|
|
May 14, 2020
|
What are the impacts on the family unit from visitation restrictions during an infectious disease outbreak and how can we support the families?
|
LTC042403 RR
|
Long Term Care
|
|
May 19, 2020
|
What are the risk factors for severity and death associated with COVID-19?
|
EPM050901 RR
|
Epidemiology & Modelling
|
|
May 19, 2020
|
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
|
LAB041601v2 RR
|
Laboratory
|
|
May 22, 2020
|
In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation?
|
EOC052102 RR
|
EOC
|
